Ii-Key/MHC class II epitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines.
about
Design of a ProDer f 1 vaccine delivered by the MHC class II pathway of antigen presentation and analysis of the effectiveness for specific immunotherapy.HER-2/neu as a target for cancer vaccines.AE37: a novel T-cell-eliciting vaccine for breast cancer.Next-generation peptide vaccines for advanced cancer.Immunologic biomarkers in prostate cancer: the AE37 paradigm
P2860
Ii-Key/MHC class II epitope hybrids: a strategy that enhances MHC class II epitope loading to create more potent peptide vaccines.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Ii-Key/MHC class II epitope hy ...... more potent peptide vaccines.
@ast
Ii-Key/MHC class II epitope hy ...... more potent peptide vaccines.
@en
type
label
Ii-Key/MHC class II epitope hy ...... more potent peptide vaccines.
@ast
Ii-Key/MHC class II epitope hy ...... more potent peptide vaccines.
@en
prefLabel
Ii-Key/MHC class II epitope hy ...... more potent peptide vaccines.
@ast
Ii-Key/MHC class II epitope hy ...... more potent peptide vaccines.
@en
P2093
P2860
P1476
Ii-Key/MHC class II epitope hy ...... more potent peptide vaccines.
@en
P2093
Catherine E Blackwell
Eric von Hofe
Minzhen Xu
Nikoletta L Kallinteris
Robert E Humphreys
Xueqing Lu
P2860
P304
P356
10.1517/14712598.6.12.1311
P407
P577
2006-12-01T00:00:00Z